-
-
-
-
-
-
-
Camp4 Therapeutics gets Australian clearance for SYNGAP1 drug trial
-
-
-
-
-
-
-
CAMP4 Therapeutics (CAMP) Reiterated at Overweight by Cantor Fitzgerald After Model Update
-
-
-
-
-
-
-
CAMP4 Therapeutics Corp (CAMP) PT Lowered to $7 at Leerink Partners
-
-
-
-
-
-
-
Piper Sandler Starts CAMP4 Therapeutics Corp (CAMP) at Overweight
-
-
-
-
-
488,244 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


